Variation in a range of mTOR-related genes associates with intracranial volume and intellectual disability

M. R. F. Reijnders, M. Kousi, G. M. van Woerden, M. Klein, J. Bralten, G. M. S. Mancini, T. van Essen, M. Proietti-Onori, E. E. J. Smeets, M. van Gastel, A. P. A. Stegmann, S. J. C. Stevens, S. H. Lelieveld, C. Gilissen, R. Pfundt, P. L. Tan, T. Kleefstra, B. Franke, Y. Elgersma, N. KatsanisH. G. Brunner*

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Abstract

De novo mutations in specific mTOR pathway genes cause brain overgrowth in the context of intellectual disability (ID). By analyzing 101 mMTOR-related genes in a large ID patient cohort and two independent population cohorts, we show that these genes modulate brain growth in health and disease. We report the mTOR activator gene RHEB as an ID gene that is associated with megalencephaly when mutated. Functional testing of mutant RHEB in vertebrate animal models indicates pathway hyperactivation with a concomitant increase in cell and head size, aberrant neuronal migration, and induction of seizures, concordant with the human phenotype. This study reveals that tight control of brain volume is exerted through a large community of mTOR-related genes. Human brain volume can be altered, by either rare disruptive events causing hyperactivation of the pathway, or through the collective effects of common alleles.

Original languageEnglish
Article number1052
Number of pages12
JournalNature Communications
Volume8
DOIs
Publication statusPublished - 20 Oct 2017

Keywords

  • TUBEROUS SCLEROSIS COMPLEX
  • MESSENGER-RNA TRANSLATION
  • IN-VIVO
  • INTRACTABLE EPILEPSY
  • CORTICAL DEVELOPMENT
  • MIGRATION DEFICITS
  • SOMATIC MUTATIONS
  • MAMMALIAN TARGET
  • CEREBRAL-CORTEX
  • SET ANALYSIS

Cite this